|
Jul 23
|
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders
|
|
Jul 15
|
Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug
|
|
Jul 14
|
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
|
|
Feb 19
|
February 2025's Top US Penny Stocks To Consider
|
|
Feb 11
|
ESSA Pharma: Fiscal Q1 Earnings Snapshot
|
|
Feb 11
|
ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024
|
|
Jan 1
|
3 Promising US Penny Stocks With Market Caps Under $80M
|
|
May 14
|
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
|
|
Apr 9
|
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
|
|
Apr 8
|
ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
|
|
Mar 8
|
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
|
|
Jan 22
|
ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains
|
|
Dec 21
|
These Stocks under $10 Are Poised To Explode
|
|
Dec 20
|
EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…
|